来自国家骨髓增生异常综合征（MDS）研究的MDS患者外周血与骨髓突变之间的相关性 - Suppr

Correlation between peripheral blood and bone marrow mutations among patients with MDS from the National MDS Study.

作者信息

DeZern Amy E, Goll Johannes B, Jensen Travis L, Nonavinkere Srivatsan Sridhar, Gillis Nancy K, Abel Gregory A, Padron Eric, Deeg H Joachim, Al Baghdadi Tareq, Liu Jane Jijun, Komrokji Rami S, Gore Steven D, Saber Wael, Bejar Rafael, Walter Matthew J, Lindsley R Coleman, Sherman Seth, DiFronzo Nancy, Sekeres Mikkael A

机构信息

Johns Hopkins University, Baltimore, MD.

The Emmes Company, Rockville, MD.

出版信息

Blood Neoplasia. 2024 Jun 12;1(3):100026. doi: 10.1016/j.bneo.2024.100026. eCollection 2024 Sep.

DOI:10.1016/j.bneo.2024.100026

PMID:40453059

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12082164/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a3b/12082164/1d0c090d93be/BNEO_NEO-2024-000257-gr1.jpg

相似文献

Correlation between peripheral blood and bone marrow mutations among patients with MDS from the National MDS Study.

Blood Neoplasia. 2024 Jun 12;1(3):100026. doi: 10.1016/j.bneo.2024.100026. eCollection 2024 Sep.

Integrated Immune Landscape Analysis of RNA Splicing Factor-Mutant AML and Higher risk MDS Treated with Azacitidine ± Durvalumab.

Ther Adv Hematol. 2025 Jun 21;16:20406207251347344. doi: 10.1177/20406207251347344. eCollection 2025.

Instructive interaction between myelodysplastic hematopoiesis and the bone marrow microenvironment at the single-cell level.

Blood Neoplasia. 2024 May 21;1(3):100021. doi: 10.1016/j.bneo.2024.100021. eCollection 2024 Sep.

Plasma Oligomer β-Amyloid and White Matter Microstructural Integrity in Cognitively Normal Older Adults According to Cerebral Amyloid Deposition.

J Prev Alzheimers Dis. 2023;10(4):837-846. doi: 10.14283/jpad.2023.87.

Long-Term Transfusion Independence with Luspatercept Versus Epoetin Alfa in Erythropoiesis-Stimulating Agent-Naive, Lower-Risk Myelodysplastic Syndromes in the COMMANDS Trial.

Adv Ther. 2025 May 16. doi: 10.1007/s12325-025-03208-5.

Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders.

Cochrane Database Syst Rev. 2018 May 14;5(5):CD012342. doi: 10.1002/14651858.CD012342.pub2.

Long-term hormone therapy for perimenopausal and postmenopausal women.

Cochrane Database Syst Rev. 2017 Jan 17;1(1):CD004143. doi: 10.1002/14651858.CD004143.pub5.

Prevalence and determinants of eating disorder risk behaviours among adult women in Denmark: findings from nationwide cross-sectional health surveys between 2000 and 2023.

J Eat Disord. 2025 Jun 16;13(1):112. doi: 10.1186/s40337-025-01318-7.

Thrombopoietin mimetics for patients with myelodysplastic syndromes.

Cochrane Database Syst Rev. 2017 Sep 30;9(9):CD009883. doi: 10.1002/14651858.CD009883.pub2.

Interventions for treating simple bone cysts in the long bones of children.

Cochrane Database Syst Rev. 2017 Feb 4;2(2):CD010847. doi: 10.1002/14651858.CD010847.pub3.

本文引用的文献

Parallel genomic analysis from paired bone marrow and peripheral blood samples of 200 cytopenic patients.

Leukemia. 2024 Jul;38(7):1626-1629. doi: 10.1038/s41375-024-02297-5. Epub 2024 May 28.

Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies.

Blood Adv. 2023 Oct 24;7(20):6120-6129. doi: 10.1182/bloodadvances.2023010061.

Myeloid NGS Analyses of Paired Samples from Bone Marrow and Peripheral Blood Yield Concordant Results: A Prospective Cohort Analysis of the AGMT Study Group.

Cancers (Basel). 2023 Apr 14;15(8):2305. doi: 10.3390/cancers15082305.

Blood Adv. 2023 Jul 25;7(14):3506-3515. doi: 10.1182/bloodadvances.2022009000.

Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions.

Blood Adv. 2023 Jul 25;7(14):3749-3759. doi: 10.1182/bloodadvances.2022008578.

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.

Leukemia. 2022 Jul;36(7):1703-1719. doi: 10.1038/s41375-022-01613-1. Epub 2022 Jun 22.

NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022.

J Natl Compr Canc Netw. 2022 Feb;20(2):106-117. doi: 10.6004/jnccn.2022.0009.

Failure to Detect Mutations in U2AF1 due to Changes in the GRCh38 Reference Sequence.

J Mol Diagn. 2022 Mar;24(3):219-223. doi: 10.1016/j.jmoldx.2021.10.013. Epub 2022 Jan 15.

Relationship between clone metrics and clinical outcome in clonal cytopenia.

Blood. 2021 Sep 16;138(11):965-976. doi: 10.1182/blood.2021011323.

Mutational analysis of hematologic neoplasms in 164 paired peripheral blood and bone marrow samples by next-generation sequencing.

Blood Adv. 2020 Sep 22;4(18):4362-4365. doi: 10.1182/bloodadvances.2020002306.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Correlation between peripheral blood and bone marrow mutations among patients with MDS from the National MDS Study.

作者信息

机构信息

Johns Hopkins University, Baltimore, MD.

The Emmes Company, Rockville, MD.

出版信息

Blood Neoplasia. 2024 Jun 12;1(3):100026. doi: 10.1016/j.bneo.2024.100026. eCollection 2024 Sep.

DOI:10.1016/j.bneo.2024.100026

PMID:40453059

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12082164/

Abstract

摘要

相似文献

Correlation between peripheral blood and bone marrow mutations among patients with MDS from the National MDS Study.

Blood Neoplasia. 2024 Jun 12;1(3):100026. doi: 10.1016/j.bneo.2024.100026. eCollection 2024 Sep.

Integrated Immune Landscape Analysis of RNA Splicing Factor-Mutant AML and Higher risk MDS Treated with Azacitidine ± Durvalumab.

Ther Adv Hematol. 2025 Jun 21;16:20406207251347344. doi: 10.1177/20406207251347344. eCollection 2025.

Instructive interaction between myelodysplastic hematopoiesis and the bone marrow microenvironment at the single-cell level.

Blood Neoplasia. 2024 May 21;1(3):100021. doi: 10.1016/j.bneo.2024.100021. eCollection 2024 Sep.

Plasma Oligomer β-Amyloid and White Matter Microstructural Integrity in Cognitively Normal Older Adults According to Cerebral Amyloid Deposition.

J Prev Alzheimers Dis. 2023;10(4):837-846. doi: 10.14283/jpad.2023.87.

Long-Term Transfusion Independence with Luspatercept Versus Epoetin Alfa in Erythropoiesis-Stimulating Agent-Naive, Lower-Risk Myelodysplastic Syndromes in the COMMANDS Trial.

Adv Ther. 2025 May 16. doi: 10.1007/s12325-025-03208-5.

Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders.

Cochrane Database Syst Rev. 2018 May 14;5(5):CD012342. doi: 10.1002/14651858.CD012342.pub2.

Long-term hormone therapy for perimenopausal and postmenopausal women.

Cochrane Database Syst Rev. 2017 Jan 17;1(1):CD004143. doi: 10.1002/14651858.CD004143.pub5.

Prevalence and determinants of eating disorder risk behaviours among adult women in Denmark: findings from nationwide cross-sectional health surveys between 2000 and 2023.

J Eat Disord. 2025 Jun 16;13(1):112. doi: 10.1186/s40337-025-01318-7.

Thrombopoietin mimetics for patients with myelodysplastic syndromes.

Cochrane Database Syst Rev. 2017 Sep 30;9(9):CD009883. doi: 10.1002/14651858.CD009883.pub2.

Interventions for treating simple bone cysts in the long bones of children.

Cochrane Database Syst Rev. 2017 Feb 4;2(2):CD010847. doi: 10.1002/14651858.CD010847.pub3.

本文引用的文献

Parallel genomic analysis from paired bone marrow and peripheral blood samples of 200 cytopenic patients.

Leukemia. 2024 Jul;38(7):1626-1629. doi: 10.1038/s41375-024-02297-5. Epub 2024 May 28.

Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies.

Blood Adv. 2023 Oct 24;7(20):6120-6129. doi: 10.1182/bloodadvances.2023010061.

Myeloid NGS Analyses of Paired Samples from Bone Marrow and Peripheral Blood Yield Concordant Results: A Prospective Cohort Analysis of the AGMT Study Group.

Cancers (Basel). 2023 Apr 14;15(8):2305. doi: 10.3390/cancers15082305.

Blood Adv. 2023 Jul 25;7(14):3506-3515. doi: 10.1182/bloodadvances.2022009000.

Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions.

Blood Adv. 2023 Jul 25;7(14):3749-3759. doi: 10.1182/bloodadvances.2022008578.

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.

Leukemia. 2022 Jul;36(7):1703-1719. doi: 10.1038/s41375-022-01613-1. Epub 2022 Jun 22.

NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022.

J Natl Compr Canc Netw. 2022 Feb;20(2):106-117. doi: 10.6004/jnccn.2022.0009.

Failure to Detect Mutations in U2AF1 due to Changes in the GRCh38 Reference Sequence.

J Mol Diagn. 2022 Mar;24(3):219-223. doi: 10.1016/j.jmoldx.2021.10.013. Epub 2022 Jan 15.

Relationship between clone metrics and clinical outcome in clonal cytopenia.

Blood. 2021 Sep 16;138(11):965-976. doi: 10.1182/blood.2021011323.

Mutational analysis of hematologic neoplasms in 164 paired peripheral blood and bone marrow samples by next-generation sequencing.

Blood Adv. 2020 Sep 22;4(18):4362-4365. doi: 10.1182/bloodadvances.2020002306.

Correlation between peripheral blood and bone marrow mutations among patients with MDS from the National MDS Study.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Correlation between peripheral blood and bone marrow mutations among patients with MDS from the National MDS Study.

作者信息

机构信息

出版信息

相似文献

本文引用的文献